Effect of Lovastatin on Muscarinic Acetylcholine Receptor and Its Relationship with ERK Signal Pathway

Longchun TAN,Liang ZHAO,Chengmin DENG,Xianhong LIU,Zhizhong GUAN
DOI: https://doi.org/10.19367/j.cnki.1000-2707.2017.01.001
2017-01-01
Abstract:[ Abstract]Objective:To investigate the influence of lovastatin on muscarinic acetylcholine receptors ( mAChRs)and extracellular signal-regulated kinase( ERK)signaling pathway. Methods:The pri-mary cultured rat hippocampal neurons were used in 2 ways.(1)Cells were treated with antagonist of mAChRs atropine or inhibitor of ERK U0126 for 2 h,and then divided into three groups according to the following treatment:control group,atropine group( 100 μmol/L atropine ),and U0126 group (10 μmol/L U0126);(2)After treated by atropine or U0126 alone or combined with lovastatin, Cells were divided into four groups:control group,atropine plus lovastatin group,and U0126 plus lov-astatin group. The protein expression of M1 mAChR,p-ERK1/2,and phospho-ERK1/2 were detected by Western blotting. Results:Compared with control group,100 μmol/L atropine or 10 μmol/L U0126 reduced the level of phospho-ERK1/2( P ﹤0. 05 ),but did not influence the level of M1 mAChR and p-ERK1/2. Compared with control group,0. 1μmol/L lovastatin increased the expression levels of M1 mAChR and phospho-ERK1/2( P﹤0 . 05 ),and when the cells were treated with lovasta-tin and atropine,the elevated expression of M1 mAChR and phospho-ERK1/2 did not changed. But the expression of phospho-ERK1/2 resulted from lovastatin markedly decreased( P﹤0 . 01 )when the cells were treated with lovastatin and U0126 . Conclusion:Lovastatin might activate ERK signaling path way,and up-regulate expression of M1 mAChR. But there is no relationship between these 2 effects.
What problem does this paper attempt to address?